Study: Some GI diseases have heavier links to dementia
By
Kristen Fischer
Nov 01, 2023
People with digestive system diseases should pay special attention to try to prevent dementia, a new study warns. That’s because certain gastrointestinal problems are linked to dementia — and some...
Clinical briefs for Wednesday, June 22
By
Alicia Lasek (f3)
Jun 22, 2022
CMS proposes payment decrease of $810M for home health in 2023 … Widespread immunity keeping death rate low as COVID surges, expert say … New IBS treatment guidelines released for complications of...
Clinical Briefs for Tuesday, October 15
By
Alicia Lasek
Oct 14, 2019
Steroids used excessively to treat irritable bowel disease … ‘Optical glucometer’ for diabetes management could replace needle sticks … Common bladder drug linked to vision-threatening eye condition
Clinical Briefs for Tuesday, September 17
By
Alicia Lasek
Sep 16, 2019
When sleep apnea is severe, blood pressure follows suit … New drug for irritable bowel syndrome FDA-approved … Small amounts of carcinogen found in Zantac: US investigates
Clinical Briefs for Tuesday, September 10
By
Alicia Lasek
Sep 09, 2019
Survey shows that Glaucoma significantly impacts well-being … 1-to-2 weekly daytime naps lower heart attack, stroke risk … New drug has potential to treat dementia-related psychosis … Cognitive behavioral...
FDA approves new oral drug to relieve constipation from opioid painkillers
By
McKnight's Staff
Apr 24, 2013
Long-term care residents who experience constipation from taking opioids to manage chronic pain may benefit from Amitiza, an oral drug recently approved by the Food and Drug Administration.